Axcan acquiring infectious disease company Mpex for an undisclosed upfront payment, plus milestones

Mpex Pharmaceuticals Inc.

U.S. / Private Biopharma

Seller

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Axcan Pharma Inc.

Canada / Mid-Cap Biopharma ($1-$50 billion)

$1,305.3m on 02/22/2008 [market cap]

Buyer

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Completed

Sample

01/01/2009

announced

01/01/2009

completed